Introduction:Current standard guidelines do not recommend a routine staging workup in early breast cancer as incidence of de novo metastasis is only 1-2%. Some of these patients are found to have a higher axillary nodal burden after surgery. This prospective study evaluated the incidence of ...
(Breast cancer specific s urvival,BCSS).筛选影响乳腺癌患者预后的高危因素,并建立列线图预测模型,根据模型中每位患者的分值进行分组,比较不同分组人群放疗与否的生存差异,筛选出放疗获益人群.结果:末次随访时间为2022年11月31日,中位随访时间98个月(11～139个月),失访28例,随访率97%.1.单因素分析,RT组5年...
Adjuvant radiotherapy after mastectomy for pT1–pT2 node negative (pN0) breast cancer: is it worth the effort? Purpose : Postoperative radiotherapy (RT) for pT1–2 pN0 breast cancer was the standard treatment in our department. Since little data on the importance o... M Voordeckers,JVD St...
cumulus cells from MI oocyte; CCMII, cumulus cells from MII oocyte; CC0PN, cumulus cells from oocyte which formed no pronuclei (0PN) after fertilization; CC2PN, cumulus cells from oocyte which formed two pronuclei (2PN) after fertilization; CCMPN, cumulus cells from oocyte which formed mult...
1. Unable to speak 2. Unable to void 3. Unable to walk 4. Lack of knowledge 1. Unable to speak, the person could not be breathing When repositioning a patient, which of the following actions by the nurse will facilitate safety for both the nurse and the patients?
Are there patient subsets at high locoregional failure risks after mastectomy for pT1/2 pN0 breast cancer that may warrant radiotherapyfeature trackingminimum cost pathscale selectionvessel enhancementPurpose: To define the ability of bone marrow mononuclear cells (BMMNC) to expand after irradiation ...
Our aim is to clarify the prognostic impact of tumor size inBRCAmutation carriers with a pT1 BC, which is currently unclear. We are especially interested in differences between pT1a, pT1b, and pT1c regarding the prognosis of node-negative breast cancer, the effect of chemotherapy, and the ...
Although this value may be controversial for postoperative anti-HER2 therapy, the present case should not be considered to be a low-risk case. When the identification of high-risk pT1a pN0 HER2-positive breast cancer is possible, postoperative anti-HER2 therapy plus chemothera...
416 Poster Adjuvant radiotherapy after mastectomy for pT1–pT2 node negative (pN0) breast cancer: is it worth the effort?doi:10.1016/S0167-8140(02)82728-1ELSEVIERRadiotherapy & Oncology
(Breast cancer specific s urvival,BCSS).筛选影响乳腺癌患者预后的高危因素,并建立列线图预测模型,根据模型中每位患者的分值进行分组,比较不同分组人群放疗与否的生存差异,筛选出放疗获益人群.结果:末次随访时间为2022年11月31日,中位随访时间98个月(11～139个月),失访28例,随访率97%.1.单因素分析,RT组5年...